A Study Of Cell Growth, Division And Programmed Differentiation By Simulation And Experiments.

[1]  Patrik D'haeseleer,et al.  Genetic network inference: from co-expression clustering to reverse engineering , 2000, Bioinform..

[2]  S. Fields.  High‐throughput two‐hybrid analysis , 2005, The FEBS journal.

[3]  C. Proud,et al.  Heat Shock Increases the Association of Binding Protein-1 with Initiation Factor 4E* , 1997, The Journal of Biological Chemistry.

[4]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[5]  J Wade Harper,et al.  The anaphase-promoting complex: it's not just for mitosis any more. , 2002, Genes & development.

[6]  J. Biggs,et al.  Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. , 1995, Cancer research.

[7]  Joseph M. Calo,et al.  Sensitivity analysis in chemical kinetics: Recent developments and computational comparisons , 1984 .

[8]  S. Monti,et al.  Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. , 2003, Anticancer research.

[9]  P. Riegman,et al.  The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. , 1991, Molecular endocrinology.

[10]  E. Meese,et al.  Overexpression of the eukaryotic translation initiation factor 4G (eIF4G‐1) in squamous cell lung carcinoma , 2002, International journal of cancer.

[11]  R. Förster,et al.  Selective expression of the murine homologue of the G-protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum. , 1994, Cellular and molecular biology.

[12]  J. Tyson,et al.  Mathematical model of the cell division cycle of fission yeast. , 2001, Chaos.

[13]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[14]  J. Ni,et al.  Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer* , 2004, Journal of Biological Chemistry.

[15]  K. Nakayama,et al.  Ubiquitin ligases: cell-cycle control and cancer , 2006, Nature Reviews Cancer.

[16]  Bela Novak,et al.  Downregulation of PP2ACdc55 Phosphatase by Separase Initiates Mitotic Exit in Budding Yeast , 2006, Cell.

[17]  N. Bruchovsky,et al.  Prostate cancer: molecular biology of early progression to androgen independence. , 1999, Endocrine-related cancer.

[18]  W. Gerald,et al.  Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer , 2006, Proceedings of the National Academy of Sciences.

[19]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[20]  Katherine C. Chen,et al.  Kinetic analysis of a molecular model of the budding yeast cell cycle. , 2000, Molecular biology of the cell.

[21]  R. Levine,et al.  Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. , 2000, Experimental cell research.

[22]  S K Burley,et al.  Hierarchical phosphorylation of the translation inhibitor 4E-BP1. , 2001, Genes & development.

[23]  Edward C Stites,et al.  Network Analysis of Oncogenic Ras Activation in Cancer , 2007, Science.

[24]  S. Yeh,et al.  Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. , 2001, Journal of biological regulators and homeostatic agents.

[25]  Herschel Rabitz,et al.  The Green’s function method of sensitivity analysis in chemical kinetics , 1978 .

[26]  O. Shah,et al.  4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[27]  Western Asia,et al.  Global Cancer Facts & Figures 2007 Estimated Number of New Cancer Cases by World Area, 2007 , 2007 .

[28]  Kwang-Hyun Cho,et al.  Dynamics of biological systems: role of systems biology in medical research , 2006, Expert review of molecular diagnostics.

[29]  K. Schulze-Osthoff,et al.  Switching Akt: from survival signaling to deadly response , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  M. Bjornsti,et al.  The tor pathway: a target for cancer therapy , 2004, Nature Reviews Cancer.

[31]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. , 2004, The New England journal of medicine.

[32]  Renate Hagedorn,et al.  Representing model uncertainty in weather and climate prediction , 2005 .

[33]  Yang Cao,et al.  Sensitivity analysis of discrete stochastic systems. , 2005, Biophysical journal.

[34]  W. Merrick.  Cap-dependent and cap-independent translation in eukaryotic systems. , 2004, Gene.

[35]  S. Collins,et al.  Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide , 1979, The Journal of experimental medicine.

[36]  S. Yeh,et al.  From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Elledge,et al.  Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis , 1996, Nature.

[38]  M. Shah,et al.  Targeting the cell cycle: a new approach to cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  N. Sonenberg,et al.  PHAS-I as a link between mitogen-activated protein kinase and translation initiation. , 1994, Science.

[40]  D.M. Mount,et al.  An Efficient k-Means Clustering Algorithm: Analysis and Implementation , 2002, IEEE Trans. Pattern Anal. Mach. Intell..

[41]  P. Houghton,et al.  Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival , 2008, Cancer biology & therapy.

[42]  Peter J Houghton,et al.  Lost in translation: dysregulation of cap-dependent translation and cancer. , 2004, Cancer cell.

[43]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[44]  B. George,et al.  Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. , 2006, Blood.

[45]  M. Saji,et al.  Overexpression and overactivation of Akt in thyroid carcinoma. , 2001, Cancer research.

[46]  D. Rowitch,et al.  Development of mice expressing a single D-type cyclin. , 2002, Genes & development.

[47]  James M. Roberts,et al.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle , 1992 .

[48]  C. Peschle,et al.  Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. , 1998, Journal of the National Cancer Institute.

[49]  Nathan H. Lents,et al.  Expression of Cyclin E Renders Cyclin D-CDK4 Dispensable for Inactivation of the Retinoblastoma Tumor Suppressor Protein, Activation of E2F, and G1-S Phase Progression* , 2004, Journal of Biological Chemistry.

[50]  D. Houchens,et al.  Human brain tumor xenografts in nude mice as a chemotherapy model. , 1983, European journal of cancer & clinical oncology.

[51]  C. Der,et al.  Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. , 1994, European journal of cell biology.

[52]  A. Yen,et al.  Nicotinamide Cooperates with Retinoic Acid and 1,25-Dihydroxyvitamin D3 to Regulate Cell Differentiation and Cell Cycle Arrest of Human Myeloblastic Leukemia Cells , 2009, Oncology.

[53]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[54]  Tony Pawson,et al.  NetworKIN: a resource for exploring cellular phosphorylation networks , 2007, Nucleic Acids Res..

[55]  C. Huggins,et al.  Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.

[56]  Zhen-yi Wang,et al.  Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.

[57]  Joseph M. Calo,et al.  An improved computational method for sensitivity analysis: Green's function method with ‘AIM’ , 1981 .

[58]  I. H. Koumakpayi,et al.  Expression and Nuclear Localization of ErbB3 in Prostate Cancer , 2006, Clinical Cancer Research.

[59]  Ming-Fong Lin,et al.  Suppression of LNCaP prostate cancer xenograft tumors by a prostate‐specific protein tyrosine phosphatase, prostatic acid phosphatase , 2003, The Prostate.

[60]  Rudiyanto Gunawan,et al.  Iterative approach to model identification of biological networks , 2005, BMC Bioinformatics.

[61]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[62]  Terry L. Smith,et al.  Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers , 2004, Clinical Cancer Research.

[63]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[64]  E. Hafen,et al.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.

[65]  K. Sugimoto,et al.  Evaluation of the expression of NADPH oxidase components during maturation of HL‐60 cells to neutrophil lineage , 2000, Journal of leukocyte biology.

[66]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[67]  M Monden,et al.  Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. , 2000, Cancer research.

[68]  J. Graff,et al.  eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.

[69]  M. Fussenegger,et al.  Molecular Regulation of Cell‐Cycle Progression and Apoptosis in Mammalian Cells: Implications for Biotechnology , 1998, Biotechnology progress.

[70]  S. Bornholdt,et al.  Boolean Network Model Predicts Cell Cycle Sequence of Fission Yeast , 2007, PloS one.

[71]  A. Yen,et al.  Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. , 2001, Differentiation; research in biological diversity.

[72]  S. Waxman,et al.  History of the development of arsenic derivatives in cancer therapy. , 2001, The oncologist.

[73]  A. Zetterberg,et al.  Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[74]  H. Kitano,et al.  Computational systems biology , 2002, Nature.

[75]  H. Klocker,et al.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. , 1994, Cancer research.

[76]  H. Kitano.  Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.

[77]  Olaf Wolkenhauer,et al.  A unified framework for unraveling the functional interaction structure of a biomolecular network based on stimulus‐response experimental data , 2005, FEBS letters.

[78]  Punit Marathe,et al.  N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. , 2004, Journal of medicinal chemistry.

[79]  B. Paschal,et al.  Mechanisms of Receptor‐Mediated Nuclear Import and Nuclear Export , 2005, Traffic.

[80]  A. De Benedetti,et al.  Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma , 1997, Cancer.

[81]  R. Mohammad,et al.  Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  I. Pastan,et al.  Apoptosis induced by immunotoxins used in the treatment of hematologic malignancies , 2000, International journal of cancer.

[83]  A. Yen,et al.  Retinoic acid increases amount of phosphorylated raf; Ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced go arrest is , 2000, In Vitro Cellular & Developmental Biology - Animal.

[84]  A. Yen,et al.  c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine. , 1990, Cancer research.

[85]  W. E. Stewart,et al.  Sensitivity analysis of initial value problems with mixed odes and algebraic equations , 1985 .

[86]  Francis J Doyle,et al.  Identifying fragilities in biochemical networks: robust performance analysis of Fas signaling-induced apoptosis. , 2008, Biophysical journal.

[87]  P. Russell,et al.  Role of the Akt pathway in prostate cancer. , 2009, Current cancer drug targets.

[88]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[89]  J. Doyle,et al.  Reverse Engineering of Biological Complexity , 2002, Science.

[90]  A. M. Dunker.  The decoupled direct method for calculating sensitivity coefficients in chemical kinetics , 1984 .

[91]  F. Allgöwer,et al.  Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise. , 2005, Systems biology.

[92]  U. Alon,et al.  Robustness in bacterial chemotaxis , 2022 .

[93]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[94]  F. Cross,et al.  Testing a mathematical model of the yeast cell cycle. , 2002, Molecular biology of the cell.

[95]  J. Mcconnell.  Prostatic growth: new insights into hormonal regulation. , 1995, British journal of urology.

[96]  S. Gygi,et al.  Serum‐stimulated, rapamycin‐sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI , 2000, The EMBO journal.

[97]  D. Conte,et al.  Deregulation of cyclin E in breast cancer. , 1995, Oncogene.

[98]  D. Longo,et al.  Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model , 2007, Leukemia.

[99]  L. Seymour,et al.  Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  Roger J. Davis,et al.  Phosphorylation of NFATc4 by p38 Mitogen-Activated Protein Kinases , 2002, Molecular and Cellular Biology.

[101]  G. Coetzee,et al.  Prostate specific antigen gene regulation by androgen receptor , 2004, Journal of cellular biochemistry.

[102]  Tak W. Mak,et al.  Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.

[103]  L. You,et al.  Evolutionary design on a budget: robustness and optimality of bacteriophage T7. , 2006, Systems biology.

[104]  Stefan Bornholdt,et al.  Boolean network models of cellular regulation: prospects and limitations , 2008, Journal of The Royal Society Interface.

[105]  R. Milo,et al.  Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[106]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[107]  John D. Ramsdell,et al.  Estimation of Sparse Jacobian Matrices , 1983 .

[108]  J. Lawrence,et al.  Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[109]  J. Stelling,et al.  Robustness properties of circadian clock architectures. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[110]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[111]  A. Murray,et al.  Cyclin is degraded by the ubiquitin pathway , 1991, Nature.

[112]  F. Piccioni,et al.  Androgen 5‐Alpha‐Reductase Type 2 is Highly Expressed and Active in Rat Spinal Cord Motor Neurones , 2003, Journal of neuroendocrinology.

[113]  T. Jaakkola,et al.  Bayesian Network Approach to Cell Signaling Pathway Modeling , 2002, Science's STKE.

[114]  Gary D Bader,et al.  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.

[115]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[116]  M. Kuo,et al.  Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells , 1999, British Journal of Cancer.

[117]  L. Mahimainathan,et al.  Inactivation of Platelet-derived Growth Factor Receptor by the Tumor Suppressor PTEN Provides a Novel Mechanism of Action of the Phosphatase* , 2004, Journal of Biological Chemistry.

[118]  R. Chetty,et al.  Cyclin D1 and human neoplasia. , 1998, Molecular pathology : MP.

[119]  A. De Benedetti,et al.  Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. , 1999, Archives of otolaryngology--head & neck surgery.

[120]  M. Andjelkovic,et al.  Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.

[121]  A. Yen,et al.  Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. , 1998, Cancer research.

[122]  Bernard Ducommun,et al.  Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases , 2005, Molecular Cancer Therapeutics.

[123]  D. Lauffenburger,et al.  A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model , 2001, Biotechnology progress.

[124]  Eduardo Sontag,et al.  Inference of signaling and gene regulatory networks by steady-state perturbation experiments: structure and accuracy. , 2005, Journal of theoretical biology.

[125]  Roland Eils,et al.  Optimal Experimental Design for Parameter Estimation of a Cell Signaling Model , 2009, PLoS Comput. Biol..

[126]  R. Evans,et al.  Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.

[127]  J R Lorsch,et al.  Kinetic dissection of fundamental processes of eukaryotic translation initiation in vitro , 1999, The EMBO journal.

[128]  Celia Arnaud.  Systems biology's clinical future , 2006 .

[129]  K. Marks,et al.  Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T. , 1999, Experimental cell research.

[130]  R. Klein,et al.  Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases , 1999, Medical oncology.

[131]  J. Kerns,et al.  Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue. , 2000, Cancer research.

[132]  A. Aderem.  Systems Biology: Its Practice and Challenges , 2005, Cell.

[133]  L. Pirola,et al.  Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. , 1998, Science.

[134]  M. Roussel,et al.  A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2 , 1999, Oncogene.

[135]  Michael J. Wilson,et al.  Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the gleason grading system , 1988, The Prostate.

[136]  Sophia Ananiadou,et al.  Text mining and its potential applications in systems biology. , 2006, Trends in biotechnology.

[137]  J. Varner,et al.  A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials , 2008, PloS one.

[138]  Masa Tsuchiya,et al.  Can Complex Cellular Processes be Governed by Simple Linear Rules? , 2009, J. Bioinform. Comput. Biol..

[139]  S. Srivastava,et al.  Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. , 2005, Endocrine-related cancer.

[140]  G. Murphy,et al.  A prostate antigen in sera of prostatic cancer patients. , 1980, Cancer research.

[141]  B. L. Welch.  The generalisation of student's problems when several different population variances are involved. , 1947, Biometrika.

[142]  H. Klocker,et al.  Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides , 2000, Cancer Gene Therapy.

[143]  Jeremy S Edwards,et al.  MAPK cascade possesses decoupled controllability of signal amplification and duration. , 2004, Biophysical journal.

[144]  N. Sonenberg,et al.  Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[145]  Deyan Luan,et al.  Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies , 2007, PLoS Comput. Biol..

[146]  J. Wade Harper,et al.  Drug discovery in the ubiquitin–proteasome system , 2006, Nature Reviews Drug Discovery.

[147]  S. Mader,et al.  Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines , 2003, Leukemia.

[148]  Mollianne J. McGahren,et al.  Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms , 2001, Molecular and Cellular Biology.

[149]  A. Miyauchi,et al.  Expression of cdc25A and cdc25B phosphatase in breast carcinoma , 2004, Breast cancer.

[150]  B. Aguda,et al.  The kinetic origins of the restriction point in the mammalian cell cycle , 1999, Cell proliferation.

[151]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[152]  A. Gingras,et al.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.

[153]  G. Murphy,et al.  Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. , 1982, Journal of the National Cancer Institute.

[154]  A. Ciechanover,et al.  Components of Ubiquitin-Protein Ligase System , 1983 .

[155]  Christopher G. Proud,et al.  Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation? , 2002, European journal of biochemistry.

[156]  D. Ballon,et al.  The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[157]  I. Pastan,et al.  Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. , 2004, Blood.

[158]  Eduardo D. Sontag,et al.  Inferring dynamic architecture of cellular networks using time series of gene expression, protein and metabolite data , 2004, Bioinform..

[159]  Isabelle Bedrosian,et al.  Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.

[160]  H. Kanetake,et al.  Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma , 1991, The Prostate.

[161]  Peer Bork,et al.  KEGG Atlas mapping for global analysis of metabolic pathways , 2008, Nucleic Acids Res..

[162]  William R Sellers,et al.  PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. , 2003, Cancer treatment and research.

[163]  R. Förster,et al.  Transmembrane topology of the lymphocyte-specific G-protein-coupled receptor BLR1: analysis by flow cytometry and immunocytochemistry. , 1994, Cellular and molecular biology.

[164]  B. Aguda,et al.  A quantitative analysis of the kinetics of the G(2) DNA damage checkpoint system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[165]  Q. Ouyang,et al.  The yeast cell-cycle network is robustly designed. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[166]  Zhilin Qu,et al.  Regulation of the mammalian cell cycle: a model of the G1-to-S transition. , 2003, American journal of physiology. Cell physiology.

[167]  K. Steiglitz,et al.  Adaptive step size random search , 1968 .

[168]  E. Gelmann,et al.  Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[169]  Christine C. Hudson,et al.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. , 2000, Cancer research.

[170]  W. Miller,et al.  JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. , 2004, Blood.

[171]  Noah Craft,et al.  A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.

[172]  E. Karsenti,et al.  Activation of the phosphatase activity of human cdc25A by a cdk2‐cyclin E dependent phosphorylation at the G1/S transition. , 1994, The EMBO journal.

[173]  A. Shah,et al.  Essential Role of the NADPH Oxidase Subunit p47phox in Endothelial Cell Superoxide Production in Response to Phorbol Ester and Tumor Necrosis Factor-&agr; , 2002, Circulation research.

[174]  R. Milo,et al.  Topological generalizations of network motifs. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[175]  V. Agol,et al.  Molecular mechanisms of translation initiation in eukaryotes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[176]  B. Snel,et al.  Comparative assessment of large-scale data sets of protein–protein interactions , 2002, Nature.

[177]  Ken Garber,et al.  Missing the target: ubiquitin ligase drugs stall. , 2005, Journal of the National Cancer Institute.

[178]  R. Heinrich,et al.  Control of MAPK signalling: from complexity to what really matters , 2005, Oncogene.

[179]  Kiyoko F. Aoki-Kinoshita,et al.  Gene annotation and pathway mapping in KEGG. , 2007, Methods in molecular biology.

[180]  Robert J. Gelinas,et al.  Sensitivity analysis of ordinary differential equation systems—A direct method , 1976 .

[181]  H. Arnqvist,et al.  Inhibition of puromycin-induced apoptosis in breast cancer cells by IGF-I occurs simultaneously with increased protein synthesis. , 2004, Neoplasma.

[182]  T. Meng,et al.  Tyrosine Phosphorylation of c-ErbB-2 Is Regulated by the Cellular Form of Prostatic Acid Phosphatase in Human Prostate Cancer Cells* , 1998, The Journal of Biological Chemistry.

[183]  S. Batra,et al.  Establishment and characterization of androgen‐independent human prostate cancer LNCaP cell model , 2002, The Prostate.

[184]  Masa Tsuchiya,et al.  Signaling Flux Redistribution at Toll-Like Receptor Pathway Junctions , 2008, PloS one.

[185]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[186]  J. Bartek,et al.  checkpoint . D-cyclin-dependent kinase-pRb-controlled G 1 from diverse classes of receptors at the cyclin Convergence of mitogenic signalling cascades , 1996 .

[187]  K. H. Lee,et al.  The statistical mechanics of complex signaling networks: nerve growth factor signaling , 2004, Physical biology.

[188]  S. Groshen,et al.  Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. , 1998, Cancer research.

[189]  G. Wagner,et al.  Translation initiation: structures, mechanisms and evolution , 2004, Quarterly Reviews of Biophysics.

[190]  M. Fussenegger,et al.  A mathematical model of caspase function in apoptosis , 2000, Nature Biotechnology.

[191]  B. Hemmings,et al.  Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.

[192]  F. Doyle,et al.  A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutions. , 2004, Genome research.

[193]  J. Bartek,et al.  Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression , 1996, Molecular and cellular biology.

[194]  S. Minucci,et al.  Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to Arsenic Trioxide* , 2002, The Journal of Biological Chemistry.

[195]  J. Schellens,et al.  E7070: a novel synthetic sulfonamide targeting the cell cycle progression for the treatment of cancer. , 2002, Anti-cancer drugs.

[196]  M. Roberson,et al.  Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. , 2001, European journal of cell biology.

[197]  Jesper Tegnér,et al.  Reverse engineering gene networks using singular value decomposition and robust regression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[198]  T. Naoe,et al.  A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. , 2006, Blood.

[199]  S. Hoshino,et al.  Molecular Mechanism of Human CD38 Gene Expression by Retinoic Acid , 1998, The Journal of Biological Chemistry.

[200]  C. J. Morton-firth.  Stochastic simulation of cell signaling pathways , 1998 .

[201]  John J Tyson,et al.  A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.

[202]  Gopal Singh,et al.  eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling , 2008, Molecular Cancer Therapeutics.

[203]  A. Senderowicz,et al.  Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials , 2004, Investigational New Drugs.

[204]  J. Labbé,et al.  The anaphase-promoting complex: a key factor in the regulation of cell cycle , 2005, Oncogene.

[205]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[206]  J. Arnold,et al.  An ensemble method for identifying regulatory circuits with special reference to the qa gene cluster of Neurospora crassa , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[207]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[208]  A. Yen,et al.  A MAPK-positive Feedback Mechanism for BLR1 Signaling Propels Retinoic Acid-triggered Differentiation and Cell Cycle Arrest* , 2008, Journal of Biological Chemistry.

[209]  I. Pastan,et al.  HA22 (R490A) Is a Recombinant Immunotoxin with Increased Antitumor Activity without an Increase in Animal Toxicity , 2005, Clinical Cancer Research.

[210]  J. Bartlett,et al.  Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer , 2007, British Journal of Cancer.

[211]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[212]  A. Martelli,et al.  Phosphoinositide 3‐kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells , 2005, Journal of cellular physiology.

[213]  S. Fields,et al.  The two-hybrid system: an assay for protein-protein interactions. , 1994, Trends in genetics : TIG.

[214]  J. Tyson.  Modeling the cell division cycle: cdc2 and cyclin interactions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[215]  S. Reed,et al.  Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.

[216]  William R. Sellers,et al.  PI3K/PTEN/Akt Pathway , 2004 .

[217]  Masa Tsuchiya,et al.  Predicting Novel Features of Toll-Like Receptor 3 Signaling in Macrophages , 2009, PloS one.

[218]  Venkat Venkatasubramanian,et al.  Spontaneous emergence of complex optimal networks through evolutionary adaptation , 2004, Comput. Chem. Eng..

[219]  J. Stelling,et al.  Robustness of Cellular Functions , 2004, Cell.

[220]  R. Förster,et al.  The G protein‐coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues , 1993, European journal of immunology.

[221]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[222]  A. Yen,et al.  Nongenomic vitamin D3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation , 2001, In Vitro Cellular & Developmental Biology - Animal.

[223]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[224]  J. Locasale,et al.  Maximum Entropy Reconstructions of Dynamic Signaling Networks from Quantitative Proteomics Data , 2009, PloS one.

[225]  A. Yen,et al.  c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells. , 2008, Cancer research.

[226]  M. Tsai,et al.  Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer , 2003, Oncogene.

[227]  M. Tallman,et al.  The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. , 2004, Leukemia research.

[228]  C. Hellen,et al.  Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. , 2004, Genes & development.

[229]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[230]  I. Pastan,et al.  Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin. , 1989, The Journal of biological chemistry.

[231]  Costas D. Maranas,et al.  Large-scale inference of the transcriptional regulation of Bacillus subtilis , 2005, Comput. Chem. Eng..

[232]  K. Knudsen,et al.  TCDD blocks androgen-dependent cell proliferation of LNCaP cells through modulation of RB phosphorylation * , 2004 .

[233]  N. Sonenberg,et al.  Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.

[234]  A. Senderowicz.  Small-molecule cyclin-dependent kinase modulators , 2003, Oncogene.

[235]  J. Lambeth,et al.  The neutrophil NADPH oxidase. , 2002, Archives of biochemistry and biophysics.

[236]  A. Levin,et al.  Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. , 1996, Blood.

[237]  D. Longo,et al.  Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity. , 1992, Cancer research.

[238]  P. Bork,et al.  Systematic Discovery of In Vivo Phosphorylation Networks , 2007, Cell.

[239]  S. Leibler,et al.  Robustness in simple biochemical networks , 1997, Nature.

[240]  A. Ciechanover,et al.  Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[241]  D. Brown,et al.  Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid- and DMSO-induced early events. , 1987, Experimental cell research.

[242]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[243]  D. Fell,et al.  Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.

[244]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[245]  W. Kolch,et al.  Protein kinase C alpha activates RAF-1 by direct phosphorylation. , 1993, Nature.

[246]  S. Volarevic,et al.  Role of S6 phosphorylation and S6 kinase in cell growth. , 2001, Progress in nucleic acid research and molecular biology.

[247]  Roger J. Davis,et al.  cPLA2 is phosphorylated and activated by MAP kinase , 1993, Cell.

[248]  Ming-Shyue Lee,et al.  Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells , 2000, Oncogene.

[249]  K. Akashi,et al.  Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.

[250]  R. Caprioli,et al.  Determination of protein-protein interactions by matrix-assisted laser desorption/ionization mass spectrometry. , 1998, Journal of mass spectrometry : JMS.

[251]  G. Clinton,et al.  The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase. , 1988, Molecular and cellular biology.

[252]  Peter W. Zandstra,et al.  Sensitivity Analysis of Intracellular Signaling Pathway Kinetics Predicts Targets for Stem Cell Fate Control , 2007, PLoS Comput. Biol..

[253]  R. Evans,et al.  Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[254]  A. Arkin,et al.  Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. , 1998, Genetics.

[255]  P. Uetz,et al.  High-throughput screening for protein-protein interactions using two-hybrid assay. , 2000, Methods in enzymology.

[256]  Mark A. Kramer,et al.  Sensitivity analysis of systems of differential and algebraic equations , 1985 .

[257]  D. Lauffenburger,et al.  Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data , 2009, Molecular systems biology.

[258]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[259]  H. Kitano.  A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.

[260]  J. Hershey,et al.  Translational control in mammalian cells. , 1991, Annual review of biochemistry.

[261]  J. Stelling,et al.  Ensemble modeling for analysis of cell signaling dynamics , 2007, Nature Biotechnology.

[262]  Bernard Ducommun,et al.  Inhibitors of the CDC25 phosphatases. , 2003, Progress in cell cycle research.

[263]  T. Golub,et al.  Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling. , 2006, Cancer research.

[264]  S. Liou,et al.  Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[265]  Bernard Ducommun,et al.  CDC25 phosphatases in cancer cells: key players? Good targets? , 2007, Nature Reviews Cancer.

[266]  Jeffrey Varner,et al.  Modeling and Analysis of the Molecular Basis of Pain in Sensory Neurons , 2009, PloS one.

[267]  John Doyle,et al.  Complexity and robustness , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[268]  C. Wilcox,et al.  Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor. , 2003, Carcinogenesis.

[269]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[270]  P. Vihko.  Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes. , 1979, Investigative urology.

[271]  Karen E. Knudsen,et al.  AR, the cell cycle, and prostate cancer , 2008, Nuclear Receptor Signaling.

[272]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[273]  B. Alberts,et al.  Molecular Biology of the Cell (Fifth Edition) , 2008 .

[274]  Ming Tan,et al.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. , 2004, Cancer cell.

[275]  A. Ramos,et al.  Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. , 2008, Biochemical pharmacology.

[276]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[277]  Daniel J. Culkin,et al.  Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. , 1998, New England Journal of Medicine.

[278]  C. Sweep,et al.  Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer , 2003, Oncogene.

[279]  F J Doyle,et al.  Model identification of signal transduction networks from data using a state regulator problem. , 2005, Systems biology.

[280]  Kwang-Hyun Cho,et al.  Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNFα-Mediated NF-κ B Signal Transduction Pathway , 2003, Simul..

[281]  N. Gray,et al.  Control of translation initiation in animals. , 1998, Annual review of cell and developmental biology.

[282]  Avram Hershko,et al.  Ubiquitin: Roles in protein modification and breakdown , 1983, Cell.

[283]  K L Albright,et al.  Dependence of HL‐60 myeloid cell differentiation on continuous and split retinoic acid exposures: Precommitment memory associated with altered nuclear structure , 1984, Journal of cellular physiology.

[284]  Christopher R. Myers,et al.  Universally Sloppy Parameter Sensitivities in Systems Biology Models , 2007, PLoS Comput. Biol..

[285]  M. Bushell,et al.  Internal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors , 2005, Cell Death and Differentiation.

[286]  A. Willis,et al.  Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression , 2004, Oncogene.

[287]  G. Thomas,et al.  The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases , 1996, Molecular and cellular biology.

[288]  Hiroaki Kitano,et al.  Biological robustness , 2008, Nature Reviews Genetics.

[289]  Ming-Shyue Lee,et al.  DIFFERENTIAL RESPONSIVENESS OF PROSTATIC ACID PHOSPHATASE AND PROSTATE‐SPECIFIC ANTIGEN mRNA TO ANDROGEN IN PROSTATE CANCER CELLS , 2000, Cell biology international.

[290]  S. Reed,et al.  Association of human cyclin E with a periodic G1-S phase protein kinase. , 1992, Science.

[291]  J. Douros,et al.  New antitumor substances of natural origin. , 1981, Cancer treatment reviews.

[292]  H. Najm,et al.  Spectral methods for parametric sensitivity in stochastic dynamical systems. , 2007, Biophysical journal.

[293]  A. Yen,et al.  Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL‐60 cells , 2008, FEBS letters.

[294]  M. Wilkinson,et al.  Control of the eukaryotic cell cycle by MAP kinase signaling pathways , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[295]  M. C. Hu,et al.  HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. , 2000, The Journal of biological chemistry.

[296]  J. Tyson,et al.  Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. , 2001, Journal of theoretical biology.

[297]  J. Hasty,et al.  Reverse engineering gene networks: Integrating genetic perturbations with dynamical modeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[298]  Boon Chuan Low,et al.  Pathway sensitivity analysis for detecting pro‐proliferation activities of oncogenes and tumor suppressors of epidermal growth factor receptor‐extracellular signal‐regulated protein kinase pathway at altered protein levels , 2009, Cancer.

[299]  E. Crawford,et al.  The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial , 2004, The Prostate.

[300]  Ming-Shyue Lee,et al.  ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells , 2003, Oncogene.

[301]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.

[302]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[303]  Kathy Chen,et al.  Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.

[304]  S. Collins,et al.  Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .

[305]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[306]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[307]  A. De Benedetti,et al.  Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F , 1991, Molecular and cellular biology.

[308]  C. Haiman,et al.  Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[309]  J. Nevins,et al.  Regulation of the cyclin E gene by transcription factor E2F1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[310]  Dag Wedelin,et al.  Benchmarks for identification of ordinary differential equations from time series data , 2009, Bioinform..

[311]  O. Hazeki.  [Phosphoinositide 3-kinase]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[312]  I. Pastan,et al.  Role of caspases in immunotoxin-induced apoptosis of cancer cells. , 1998, Biochemistry.

[313]  Yan Geng,et al.  Cyclin E Ablation in the Mouse , 2003, Cell.

[314]  T. Dobner,et al.  Differentiation‐specific expression of a novel G protein‐coupled receptor from Burkitt's lymphoma , 1992, European journal of immunology.

[315]  K. S. Brown,et al.  Statistical mechanical approaches to models with many poorly known parameters. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[316]  K. Ross,et al.  Post-transcriptional Increases in Cyclin D Proteins through Mammalian Target of Rapamycin Activation and Androgens Induce Prostate Cancer Cell Proliferation , 2006 .

[317]  Eugene P. Dougherty,et al.  A computational algorithm for the Green's function method of sensitivity analysis in chemical kinetics , 1979 .

[318]  Xuening Wang,et al.  Activation of extracellular signal‐regulated kinases (ERKs) defines the first phase of 1,25‐dihydroxyvitamin D3‐induced differentiation of HL60 cells , 2001, Journal of cellular biochemistry.

[319]  G. Mills,et al.  Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors , 2003, Oncogene.

[320]  S. Waxman,et al.  Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. , 1999, Blood.

[321]  J E Bailey,et al.  A mathematical description of regulation of the G1-S transition of the mammalian cell cycle. , 1999, Biotechnology and bioengineering.

[322]  Patrick S Daugherty,et al.  Intracellular protein interaction mapping with FRET hybrids , 2006, Proceedings of the National Academy of Sciences.

[323]  W. Marsden.  I and J , 2012 .

[324]  L. Nazareth,et al.  Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway* , 1996, The Journal of Biological Chemistry.

[325]  Chi-Ying F. Huang,et al.  Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.